Louisiana State Employees Retirement System Makes New Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Louisiana State Employees Retirement System acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 4,300 shares of the biotechnology company’s stock, valued at approximately $1,111,000.

Other hedge funds have also recently bought and sold shares of the company. BKM Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $32,000. Provence Wealth Management Group acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $80,000. Clearstead Advisors LLC raised its position in shares of Axon Enterprise by 35.0% in the third quarter. Clearstead Advisors LLC now owns 440 shares of the biotechnology company’s stock valued at $88,000 after buying an additional 114 shares in the last quarter. UMB Bank n.a. raised its position in shares of Axon Enterprise by 11.0% in the fourth quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock valued at $115,000 after buying an additional 44 shares in the last quarter. Finally, Signaturefd LLC raised its position in shares of Axon Enterprise by 16.1% in the third quarter. Signaturefd LLC now owns 475 shares of the biotechnology company’s stock valued at $95,000 after buying an additional 66 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $301.56 on Wednesday. The firm’s fifty day moving average price is $302.15 and its two-hundred day moving average price is $260.29. The stock has a market cap of $22.76 billion, a PE ratio of 131.11 and a beta of 0.93. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The company had revenue of $432.14 million for the quarter, compared to analysts’ expectations of $418.97 million. On average, equities analysts expect that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. JMP Securities lifted their price target on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 6th. Morgan Stanley boosted their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 28th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Finally, Robert W. Baird boosted their price objective on shares of Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a research report on Thursday, February 22nd. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $312.64.

Read Our Latest Research Report on AXON

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.